ImmunoPrecise Antibodies (IPA) Competitors $1.34 +0.28 (+25.94%) Closing price 07/3/2025 03:58 PM EasternExtended Trading$1.34 0.00 (0.00%) As of 07/3/2025 04:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock IPA vs. TLSA, TIL, OGI, CYBN, NVCT, SPRO, NLTX, IPHA, LRMR, and ALTSShould you be buying ImmunoPrecise Antibodies stock or one of its competitors? The main competitors of ImmunoPrecise Antibodies include Tiziana Life Sciences (TLSA), Instil Bio (TIL), Organigram Global (OGI), Cybin (CYBN), Nuvectis Pharma (NVCT), Spero Therapeutics (SPRO), Neoleukin Therapeutics (NLTX), Innate Pharma (IPHA), Larimar Therapeutics (LRMR), and ALT5 Sigma (ALTS). These companies are all part of the "pharmaceutical products" industry. ImmunoPrecise Antibodies vs. Its Competitors Tiziana Life Sciences Instil Bio Organigram Global Cybin Nuvectis Pharma Spero Therapeutics Neoleukin Therapeutics Innate Pharma Larimar Therapeutics ALT5 Sigma Tiziana Life Sciences (NASDAQ:TLSA) and ImmunoPrecise Antibodies (NASDAQ:IPA) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their analyst recommendations, risk, earnings, institutional ownership, media sentiment, dividends, valuation and profitability. Which has more risk & volatility, TLSA or IPA? Tiziana Life Sciences has a beta of -0.05, suggesting that its share price is 105% less volatile than the S&P 500. Comparatively, ImmunoPrecise Antibodies has a beta of 0.44, suggesting that its share price is 56% less volatile than the S&P 500. Do analysts recommend TLSA or IPA? ImmunoPrecise Antibodies has a consensus target price of $4.00, suggesting a potential upside of 199.63%. Given ImmunoPrecise Antibodies' stronger consensus rating and higher probable upside, analysts plainly believe ImmunoPrecise Antibodies is more favorable than Tiziana Life Sciences.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Tiziana Life Sciences 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00ImmunoPrecise Antibodies 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00 Does the media prefer TLSA or IPA? In the previous week, ImmunoPrecise Antibodies had 1 more articles in the media than Tiziana Life Sciences. MarketBeat recorded 1 mentions for ImmunoPrecise Antibodies and 0 mentions for Tiziana Life Sciences. Tiziana Life Sciences' average media sentiment score of 0.00 equaled ImmunoPrecise Antibodies'average media sentiment score. Company Overall Sentiment Tiziana Life Sciences Neutral ImmunoPrecise Antibodies Neutral Which has stronger earnings and valuation, TLSA or IPA? Tiziana Life Sciences has higher earnings, but lower revenue than ImmunoPrecise Antibodies. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioTiziana Life SciencesN/AN/A-$11.86MN/AN/AImmunoPrecise Antibodies$18.16M3.36-$20.13M-$1.16-1.15 Do insiders and institutionals hold more shares of TLSA or IPA? 6.7% of ImmunoPrecise Antibodies shares are held by institutional investors. 39.8% of Tiziana Life Sciences shares are held by company insiders. Comparatively, 6.8% of ImmunoPrecise Antibodies shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth. Is TLSA or IPA more profitable? Tiziana Life Sciences has a net margin of 0.00% compared to ImmunoPrecise Antibodies' net margin of -190.76%. Tiziana Life Sciences' return on equity of 0.00% beat ImmunoPrecise Antibodies' return on equity.Company Net Margins Return on Equity Return on Assets Tiziana Life SciencesN/A N/A N/A ImmunoPrecise Antibodies -190.76%-88.87%-49.26% SummaryImmunoPrecise Antibodies beats Tiziana Life Sciences on 7 of the 12 factors compared between the two stocks. Get ImmunoPrecise Antibodies News Delivered to You Automatically Sign up to receive the latest news and ratings for IPA and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding IPA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart IPA vs. The Competition Export to ExcelMetricImmunoPrecise AntibodiesMEDICAL INFO SYS IndustryMedical SectorNASDAQ ExchangeMarket Cap$59.95M$2.04B$5.56B$9.04BDividend YieldN/AN/A5.24%4.01%P/E Ratio-1.1535.8727.6420.24Price / Sales3.3615.98416.55117.31Price / CashN/A55.8836.8958.10Price / Book1.448.708.035.67Net Income-$20.13M-$62.39M$3.18B$249.21M7 Day Performance20.27%2.58%2.93%3.28%1 Month Performance98.54%1.47%1.72%3.95%1 Year Performance33.50%4.09%34.39%20.98% ImmunoPrecise Antibodies Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)IPAImmunoPrecise Antibodies1.75 of 5 stars$1.34+25.9%$4.00+199.6%+33.5%$59.95M$18.16M-1.1580News CoverageTLSATiziana Life Sciences0.6752 of 5 stars$1.55-0.6%N/A+85.5%$182.28MN/A0.008TILInstil Bio2.6108 of 5 stars$29.84+7.7%$119.00+298.8%+185.4%$181.68MN/A-2.49410News CoverageOGIOrganigram Global0.532 of 5 stars$1.28-0.8%N/A-10.4%$172.78M$117.47M12.80860News CoverageCYBNCybin2.9549 of 5 stars$7.41-4.8%$86.00+1,060.6%N/A$170.39MN/A-1.6950News CoverageAnalyst RevisionNVCTNuvectis Pharma2.6299 of 5 stars$7.96-2.1%$17.00+113.6%+24.6%$169.86MN/A-7.048SPROSpero Therapeutics3.9021 of 5 stars$2.93-3.0%$5.00+70.6%+122.1%$168.85M$47.98M-2.29150NLTXNeoleukin TherapeuticsN/A$17.76-3.0%N/A-44.2%$166.91MN/A-5.7190High Trading VolumeIPHAInnate Pharma2.5329 of 5 stars$1.80flat$11.00+511.1%-8.5%$165.92M$12.62M0.00220LRMRLarimar Therapeutics1.5877 of 5 stars$2.42-6.6%$19.67+712.7%-58.6%$165.83MN/A-1.6230High Trading VolumeALTSALT5 Sigma0.1195 of 5 stars$9.13-3.6%N/AN/A$165.21M$12.53M0.00170News CoverageGap Up Related Companies and Tools Related Companies Tiziana Life Sciences Alternatives Instil Bio Alternatives Organigram Global Alternatives Cybin Alternatives Nuvectis Pharma Alternatives Spero Therapeutics Alternatives Neoleukin Therapeutics Alternatives Innate Pharma Alternatives Larimar Therapeutics Alternatives ALT5 Sigma Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:IPA) was last updated on 7/6/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredThe day and month stocks are most likely to crash nextGood News for Stocks 50-year Wall Street veteran, Marc Chaikin is stepping forward to share why history giv...Chaikin Analytics | Sponsored140% Yields From Stocks Like Tesla? Here's How (July 4th Special)Imagine getting a 140% dividend from your investments. Even better? It works with big names like Tesla, ...Investors Alley | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredTrump's ticking time bombA looming tariff deadline on July 9th could be the spark — but what’s buried inside a recent White House docum...Porter & Company | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ImmunoPrecise Antibodies Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share ImmunoPrecise Antibodies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free IPA Stock Alerts